227 related articles for article (PubMed ID: 21107711)
21. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
[TBL] [Abstract][Full Text] [Related]
22. The star target in SLE: IL-17.
Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
[TBL] [Abstract][Full Text] [Related]
23. Association of interleukin-18 and systemic lupus erythematosus.
Xu WD; Pan HF; Ye DQ
Rheumatol Int; 2013 Dec; 33(12):3055-7. PubMed ID: 23263551
[TBL] [Abstract][Full Text] [Related]
24. The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus.
Huang HT; Chen JM; Guo J; Lan Y; Wei YS
Rheumatol Int; 2016 Jun; 36(6):799-805. PubMed ID: 26769434
[TBL] [Abstract][Full Text] [Related]
25. IL-23: a promising therapeutic target for systemic lupus erythematosus.
Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
[TBL] [Abstract][Full Text] [Related]
26. Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
Karampetsou MP; Comte D; Suárez-Fueyo A; Katsuyama E; Yoshida N; Kono M; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Jan; 71(1):99-108. PubMed ID: 30058241
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.
Sarra M; Monteleone G
J Biomed Biotechnol; 2010; 2010():294582. PubMed ID: 20652041
[TBL] [Abstract][Full Text] [Related]
28. Update on the role of autophagy in systemic lupus erythematosus: A novel therapeutic target.
Pan Q; Gao C; Chen Y; Feng Y; Liu WJ; Liu HF
Biomed Pharmacother; 2015 Apr; 71():190-3. PubMed ID: 25960235
[TBL] [Abstract][Full Text] [Related]
29. TIM-3 as a new therapeutic target in systemic lupus erythematosus.
Pan HF; Zhang N; Li WX; Tao JH; Ye DQ
Mol Biol Rep; 2010 Jan; 37(1):395-8. PubMed ID: 19768575
[TBL] [Abstract][Full Text] [Related]
30. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Front Immunol; 2020; 11():624971. PubMed ID: 33597953
[TBL] [Abstract][Full Text] [Related]
31. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice.
Bubier JA; Sproule TJ; Foreman O; Spolski R; Shaffer DJ; Morse HC; Leonard WJ; Roopenian DC
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1518-23. PubMed ID: 19164519
[TBL] [Abstract][Full Text] [Related]
32. Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis.
Lorenz HM; Grünke M; Hieronymus T; Winkler S; Blank N; Rascu A; Wendler J; Geiler T; Kalden JR
Eur J Immunol; 2002 May; 32(5):1253-63. PubMed ID: 11981812
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory cytokines in systemic lupus erythematosus.
Ohl K; Tenbrock K
J Biomed Biotechnol; 2011; 2011():432595. PubMed ID: 22028588
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
Xia LP; Li BF; Shen H; Lu J
Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
[TBL] [Abstract][Full Text] [Related]
35. Association between IL-33 Gene Polymorphisms (rs1929992, rs7044343) and Systemic Lupus Erythematosus in a Chinese Han Population.
Xu W; Liu Y; Ye D
Immunol Invest; 2016 Oct; 45(7):575-83. PubMed ID: 27603301
[TBL] [Abstract][Full Text] [Related]
36. A murine autoimmune model of rheumatoid arthritis and systemic lupus erythematosus associated with deregulated production of IL-17 and IL-21.
Biswas PS; Kang K; Gupta S; Bhagat G; Pernis AB
Methods Mol Biol; 2012; 900():233-51. PubMed ID: 22933072
[TBL] [Abstract][Full Text] [Related]
37. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus.
Bubier JA; Bennett SM; Sproule TJ; Lyons BL; Olland S; Young DA; Roopenian DC
Ann N Y Acad Sci; 2007 Sep; 1110():590-601. PubMed ID: 17911475
[TBL] [Abstract][Full Text] [Related]
38. Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?
Wu YR; Hsing CH; Chiu CJ; Huang HY; Hsu YH
IUBMB Life; 2022 Feb; 74(2):143-156. PubMed ID: 34668305
[TBL] [Abstract][Full Text] [Related]
39. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
Wu XN; Ye YX; Niu JW; Li Y; Li X; You X; Chen H; Zhao LD; Zeng XF; Zhang FC; Tang FL; He W; Cao XT; Zhang X; Lipsky PE
Sci Transl Med; 2014 Jul; 6(246):246ra99. PubMed ID: 25101889
[TBL] [Abstract][Full Text] [Related]
40. Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.
Idborg H; Oke V
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
